EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/15/2023
Back to search
Official data from USPTO
PHARMOPTIMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
09/15/2023
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
03/20/2017
Registration date
11/21/2017
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/01/2023
Last transaction
09/15/2023
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/01/2017
First use in commerce
04/01/2017
Drawing code
3
Owner type
16
Owner location
hamilton, NJ
Examiner
EDWARDS, ALICIA
Law office
M60
Current location
TMO LAW OFFICE 115
Mark description
The mark consists of he literal phrase "PharmOptima". The letter "O" is depicted as the iris and pupil of an eye. Two arches of circles of varying sizes extend above and below the literal phrase "PharmOptima" connecting the letter "R" and the letter "P".
Holders and representatives
Holders
Genesis PharmOptima, LLC
Genesis PharmOptima, LLC
Representatives
Christina E. Brule Heslin Rothenberg Farley & Mesiti P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
25 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/15/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/15/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/15/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/01/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/01/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/01/2023
E815
TEAS SECTION 8 & 15 RECEIVED
11/21/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/21/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/21/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/19/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/18/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/25/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/25/2017
IUAF
USE AMENDMENT FILED
09/12/2017
EISU
TEAS STATEMENT OF USE RECEIVED
09/12/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/12/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/18/2017
PUBO
PUBLISHED FOR OPPOSITION
07/18/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/28/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/13/2017
DOCK
ASSIGNED TO EXAMINER
06/13/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/24/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/23/2017
NWAP
NEW APPLICATION ENTERED
03/23/2017
Continuous trademark protection
Get notified about every new filing that threatens PHARMOPTIMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.